Skin cancer: mass screening is out, but tech giants are in!

A lack of progress with secondary prevention, in terms of skin cancer screening and early detection, is a concern and a source of some disappointment among the dermatologist community.1,2 Early detection and treatment of melanoma is critical to maximise survival.3,4 Nevertheless, recently and for a second time the US Preventive Services Task Force (USPSTF) found insufficient evidence to recommend visual screening of adults for skin cancer following a systematic review.1,5 Where does this leave us? It may feel like some kind of impasse, but it has been suggested that perhaps we simply need to shift our focus from secondary to primary prevention.1